-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Freeline Therapeutics Holdings plc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q1 2023.
- Freeline Therapeutics Holdings plc Nonoperating Income (Expense) for the quarter ending March 31, 2023 was $21.4M, a 1366% increase year-over-year.
- Freeline Therapeutics Holdings plc annual Nonoperating Income (Expense) for 2022 was $9.84M, a 322% increase from 2021.
- Freeline Therapeutics Holdings plc annual Nonoperating Income (Expense) for 2021 was $2.33M, a 62.8% decline from 2020.
- Freeline Therapeutics Holdings plc annual Nonoperating Income (Expense) for 2020 was $6.26M, a 36.7% decline from 2019.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)